ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC16095-10mg |
|
187523-35-9 |
MaxiPost
|
0 | C16H10ClF4NO2 | |
GC16094-5mg |
|
383415-79-0 |
Neuropeptide W-23 (human)
|
0 | C119H183N35O28S | |
GC16094-1mg |
|
383415-79-0 |
Neuropeptide W-23 (human)
|
0 | C119H183N35O28S | |
GC16093-50mg |
|
2971-90-6 |
Clopidol
|
0 | C7H7Cl2NO | |
GC16092-10mM (in 1mL DMSO) |
|
209216-23-9 |
Entecavir Hydrate
|
0 | C12H15N5O3.H2O | |
GC16092-100mg |
|
209216-23-9 |
Entecavir Hydrate
|
0 | C12H15N5O3.H2O | |
GC16092-25mg |
|
209216-23-9 |
Entecavir Hydrate
|
0 | C12H15N5O3.H2O | |
GC16092-5mg |
|
209216-23-9 |
Entecavir Hydrate
|
0 | C12H15N5O3.H2O | |
GC16091-50mg |
|
121524-09-2 |
SR 58611A hydrochloride
|
0 | C22H26ClNO4.HCl | |
GC16091-10mg |
|
121524-09-2 |
SR 58611A hydrochloride
|
0 | C22H26ClNO4.HCl | |
GC16090-500mg |
|
173531-58-3 |
Naphthoquine phosphate
|
0 | C24H34ClN3O9P2 | |
GC16090-100mg |
|
173531-58-3 |
Naphthoquine phosphate
|
0 | C24H34ClN3O9P2 | |
GC16090-50mg |
|
173531-58-3 |
Naphthoquine phosphate
|
0 | C24H34ClN3O9P2 | |
GC16089-50mg |
|
100981-43-9 |
Ebrotidine
|
0 | C14H17BrN6O2S3 | |
GC16089-10mg |
|
100981-43-9 |
Ebrotidine
|
0 | C14H17BrN6O2S3 | |
GC16089-5mg |
|
100981-43-9 |
Ebrotidine
|
0 | C14H17BrN6O2S3 | |
GC16088-50mg |
|
70788-28-2 |
Flurofamide
|
0 | C7H9FN3O2P | |
GC16087-1g |
|
286930-03-8 |
Fesoterodine Fumarate
|
0 | C30H41NO7 | |
GC16087-50mg |
|
286930-03-8 |
Fesoterodine Fumarate
|
0 | C30H41NO7 | |
GC16087-10mg |
|
286930-03-8 |
Fesoterodine Fumarate
|
0 | C30H41NO7 | |